Clinical Trial Update: To Evaluate the Efficacy and Safety of SCT510 in the Treatment of Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating SCT510 for non-small cell lung cancer (non-squamous) is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Non-squamous Non-small Cell Lung Cancer

Drugs mentioned

• SCT510

Snippet

Sponsor: Sinocelltech Ltd. | Conditions: Non-squamous Cell Non-small Cell Lung Cancer | Phase 3 | Status: UNKNOWN